These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27581700)

  • 1. Ibuprofen May Increase Pharmacological Action of Valproate by Displacing It From Plasma Proteins: A Case Report.
    Lana F; Martí-Bonany J; de Leon J
    Am J Psychiatry; 2016 Sep; 173(9):941-2. PubMed ID: 27581700
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.
    De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD
    J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism.
    Reznik R; Chen RYY; Stanford P
    Australas Psychiatry; 2018 Dec; 26(6):608-611. PubMed ID: 29737183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing strategies of clozapine-fluvoxamine cotreatment.
    Lu ML; Lane HY; Jann MW; Chang WH
    J Clin Psychopharmacol; 2002 Dec; 22(6):626-8. PubMed ID: 12454566
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and biochemical correlates of "high-dose" clozapine therapy for treatment-refractory schizophrenia.
    Buckley PF; Friedman L; Krowinski AC; Eaton Y; Tronetti M; Miller DD
    Schizophr Res; 2001 Apr; 49(1-2):225-7. PubMed ID: 11428347
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials.
    Basan A; Kissling W; Leucht S
    Schizophr Res; 2004 Sep; 70(1):33-7. PubMed ID: 15246461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
    Centorrino F; Baldessarini RJ; Kando J; Frankenburg FR; Volpicelli SA; Puopolo PR; Flood JG
    Am J Psychiatry; 1994 Jan; 151(1):123-5. PubMed ID: 8267110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.
    Riesselman A; Strobl B; Cooley AT; de Leon J
    J Clin Psychopharmacol; 2013 Dec; 33(6):812-4. PubMed ID: 24113673
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent febrile illness with multisystem organ failure associated with clozapine.
    Bowen DJ; Lucas NL; Braude S
    Intern Med J; 2012 Jan; 42(1):104-6. PubMed ID: 22389904
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
    George S; Cowan C
    Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 15. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
    Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
    Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monozygotic twins concordant for response to clozapine.
    Vojvoda D; Grimmell K; Sernyak M; Mazure CM
    Lancet; 1996 Jan; 347(8993):61. PubMed ID: 8531572
    [No Abstract]   [Full Text] [Related]  

  • 17. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report.
    Paraschakis A
    Clin Neuropharmacol; 2014; 37(2):60-1. PubMed ID: 24614672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C; Adesanya A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract]   [Full Text] [Related]  

  • 19. Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: a case report.
    Chan YC; Miller KM; Shaheen N; Votolato NA; Hankins MB
    Schizophr Res; 2005 Oct; 78(2-3):343-5. PubMed ID: 16085390
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosing differences between valproic acid concentrate and divalproex sodium: a case report.
    Coffey G; Botts S; de Leon J
    J Clin Psychiatry; 2004 May; 65(5):724-5. PubMed ID: 15163266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.